Strahlentherapie und Onkologie
Journal Abbreviation: STRAHLENTHER ONKOL
ISSN: 0179-7158
eISSN: 1439-099X
Publisher: Urban & Vogel
Publications (452)
12 x 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma? (2021)
Lubgan D, Semrau S, Lambrecht U, Gaipl U, Fietkau R
Journal article
Moderate Hypofractionation in Bladder Cancer - a new Standard of Care? (2021)
Ott O
Journal article, Editorial
An easy way to determine bone mineral density and predict pelvic insufficiency fractures in patients treated with radiotherapy for cervical cancer (2021)
Kurrumeli D, Oechsner M, Weidenbaecher B, Brambs C, Loeffler M, Combs SE, Borm K, Duma MN
Journal article
Radiation oncology as part of medical education—current status and possible digital future prospects (2021)
Dapper H, Wijnen-Meijer M, Rathfelder S, Mosene K, Von Kirchbauer I, Bernhardt D, Berberat PO, Combs SE
Journal article
Re-Irradiation for Patients with Head and Neck Squamous Cell Carcinoma - A multicenter Analysis of 253 Patients of the jDEGRO Trial Group (2021)
Roesch J, Oertel M, Dobiasch S, Fabian A, Fleischmann D, Von Der Gruen J, Hering D, et al.
Conference contribution
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trial (2021)
Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, et al.
Conference contribution
Primary Results of the phase II CheckRad-CD8 Trial: First-Line Treatment of locally advanced Head and Neck Tumors with double Checkpoint Blockade and Radiotherapy dependent on intratumoral CD8+T-Cell Infiltration (2021)
Hecht M, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Klautke G, Laban S, et al.
Conference contribution
The radiation-induced Activation of Anti-tumor Immune Mechanisms is enhanced by Inhibtion of the Heat Shock Protein 90 (2021)
Ernst A, Hennel R, Krombach J, Kapfhammer H, Brix N, Zuchtriegel G, Uhl B, et al.
Conference contribution
Quality of life of patients with newly diagnosed glioblastoma during TTFields therapy in routine clinical care: first results of the TIGER study (2021)
Baehr O, Tabatabai G, Fietkau R, Goldbrunner R, Glas M
Conference contribution
Tolerability of Tumor Treating Fields in pediatric high-grade glioma patients illustrated by post-market surveillance data (2021)
Suchorska B, Lucaciu R, Jung S, Leyh J, Woelfl M, Hirt C, Scholz M
Conference contribution